Medivolve Statistics
Total Valuation
Medivolve has a market cap or net worth of 54,038. The enterprise value is 779,998.
| Market Cap | 54,038 |
| Enterprise Value | 779,998 |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Medivolve has 27.02 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 27.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | n/a |
| Float | 26.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.07 |
| EV / Sales | 1.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.74% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 16.71% |
| Revenue Per Employee | 26,645 |
| Profits Per Employee | -427,669 |
| Employee Count | 25 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 3.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.30% in the last 52 weeks. The beta is 4.33, so Medivolve's price volatility has been higher than the market average.
| Beta (5Y) | 4.33 |
| 52-Week Price Change | -82.30% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 37.43 |
| Average Volume (20 Days) | 4,300 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Medivolve had revenue of 666,137 and -10.69 million in losses. Loss per share was -0.40.
| Revenue | 666,137 |
| Gross Profit | 562,517 |
| Operating Income | -2.12M |
| Pretax Income | -2.19M |
| Net Income | -10.69M |
| EBITDA | -2.12M |
| EBIT | -2.12M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 295,839 in cash and 1.23 million in debt, giving a net cash position of -933,643 or -0.03 per share.
| Cash & Cash Equivalents | 295,839 |
| Total Debt | 1.23M |
| Net Cash | -933,643 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -12.69M |
| Book Value Per Share | -0.46 |
| Working Capital | -13.32M |
Cash Flow
| Operating Cash Flow | -837,453 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 84.44% |
| Operating Margin | -318.19% |
| Pretax Margin | -329.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Medivolve does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | -19,785.56% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 8, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Dec 8, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
Medivolve has an Altman Z-Score of -90.63. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -90.63 |
| Piotroski F-Score | n/a |